BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND COL2A1, SEDC, MGC131516, COL11A3, AOM, ANFH, ENSG00000139219, 1280
32 results:

  • 1. SLIT2 promoter hypermethylation predicts disease progression in chronic myeloid leukemia.
    Wu DL; Wang Y; Zhang TJ; Chu MQ; Xu ZJ; Yuan Q; Ma JC; Lin J; Qian J; Zhou JD
    Eur J Med Res; 2022 Nov; 27(1):259. PubMed ID: 36411451
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. MiR-24-3p attenuates IL-1β-induced chondrocyte injury associated with osteoarthritis by targeting BCL2L12.
    Xu J; Qian X; Ding R
    J Orthop Surg Res; 2021 Jun; 16(1):371. PubMed ID: 34116684
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Real-world treatment patterns and healthcare resource use in patients with acute myeloid leukemia in Western Europe.
    Kabra M; Margotto L; Manuguid F
    Future Oncol; 2021 Jul; 17(21):2769-2784. PubMed ID: 33881356
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Thioridazine requires calcium influx to induce MLL-AF6-rearranged AML cell death.
    Tregnago C; Da Ros A; Porcù E; Benetton M; Simonato M; Simula L; Borella G; Polato K; Minuzzo S; Borile G; Cogo P; Campello S; Massi A; Romagnoli R; Buldini B; Locatelli F; Pigazzi M
    Blood Adv; 2020 Sep; 4(18):4417-4429. PubMed ID: 32931582
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The incidence of cytokine release syndrome and neurotoxicity of CD19 chimeric antigen receptor-T cell therapy in the patient with acute lymphoblastic leukemia and lymphoma.
    Cao JX; Wang H; Gao WJ; You J; Wu LH; Wang ZX
    Cytotherapy; 2020 Apr; 22(4):214-226. PubMed ID: 32305113
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Safety and efficacy of talacotuzumab plus decitabine or decitabine alone in patients with acute myeloid leukemia not eligible for chemotherapy: results from a multicenter, randomized, phase 2/3 study.
    Montesinos P; Roboz GJ; Bulabois CE; Subklewe M; Platzbecker U; Ofran Y; Papayannidis C; Wierzbowska A; Shin HJ; Doronin V; Deneberg S; Yeh SP; Ozcan MA; Knapper S; Cortes J; Pollyea DA; Ossenkoppele G; Giralt S; Döhner H; Heuser M; Xiu L; Singh I; Huang F; Larsen JS; Wei AH
    Leukemia; 2021 Jan; 35(1):62-74. PubMed ID: 32203138
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Genetic Disorders in Prenatal Onset Syndromic Short Stature Identified by Exome Sequencing.
    Homma TK; Freire BL; Honjo Kawahira RS; Dauber A; Funari MFA; Lerario AM; Nishi MY; Albuquerque EV; Vasques GA; Collett-Solberg PF; Miura Sugayama SM; Bertola DR; Kim CA; Arnhold IJP; Malaquias AC; Jorge AAL
    J Pediatr; 2019 Dec; 215():192-198. PubMed ID: 31630891
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Phase I study of tirabrutinib (ONO-4059/GS-4059) in patients with relapsed or refractory B-cell malignancies in Japan.
    Munakata W; Ando K; Hatake K; Fukuhara N; Kinoshita T; Fukuhara S; Shirasugi Y; Yokoyama M; Ichikawa S; Ohmachi K; Gion N; Aoi A; Tobinai K
    Cancer Sci; 2019 May; 110(5):1686-1694. PubMed ID: 30815927
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A Pilot Study of Aberrant CpG Island Hypermethylation of
    Sun J; Zhang J; Wang Y; Li Y; Zhang R
    Int J Med Sci; 2019; 16(2):324-330. PubMed ID: 30745814
    [No Abstract]    [Full Text] [Related]  

  • 10. Hematopoietic PBX-interacting protein mediates cartilage degeneration during the pathogenesis of osteoarthritis.
    Ji Q; Xu X; Kang L; Xu Y; Xiao J; Goodman SB; Zhu X; Li W; Liu J; Gao X; Yan Z; Zheng Y; Wang Z; Maloney WJ; Ye Q; Wang Y
    Nat Commun; 2019 Jan; 10(1):313. PubMed ID: 30659184
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Squamoid eccrine ductal carcinoma.
    Jacob J; Kugelman L
    Cutis; 2018 May; 101(5):378;380;385. PubMed ID: 29894529
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Comparison of conventional cytomorphology, flow cytometry immunophenotyping, and automated cell counting of CSF for detection of CNS involvement in acute lymphoblastic leukemia.
    Jaime-Pérez JC; Borrego-López MF; Jiménez-Castillo RA; Méndez-Ramírez N; Salazar-Riojas R; Fernández LT; Gómez-Almaguer D
    Int J Lab Hematol; 2018 Apr; 40(2):169-174. PubMed ID: 29115725
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Incidence of type 2 diabetes mellitus and hyperlipidemia in patients prescribed dasatinib or nilotinib as first- or second-line therapy for chronic myelogenous leukemia in the US.
    Franklin M; Burns L; Perez S; Yerragolam D; Makenbaeva D
    Curr Med Res Opin; 2018 Feb; 34(2):353-360. PubMed ID: 29095654
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Cancer Risk After Pediatric Solid Organ Transplantation.
    Yanik EL; Smith JM; Shiels MS; Clarke CA; Lynch CF; Kahn AR; Koch L; Pawlish KS; Engels EA
    Pediatrics; 2017 May; 139(5):. PubMed ID: 28557749
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Chronic polyarthritis as isolated manifestation of toxocariasis.
    Viola GR; Giacomin MF; França CM; Sallum AM; Jacob CM; Silva CA
    Rev Bras Reumatol Engl Ed; 2016; 56(2):185-7. PubMed ID: 27267534
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Whole genome sequencing identified new somatic mutations for chronic myelomonocytic leukemia.
    Ying Y; Xie JJ; Wang HP; Mao P; Zhou W; Yang Z; Chen XY
    Eur Rev Med Pharmacol Sci; 2016; 20(2):278-84. PubMed ID: 26875896
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Drug screen in patient cells suggests quinacrine to be repositioned for treatment of acute myeloid leukemia.
    Eriksson A; Österroos A; Hassan S; Gullbo J; Rickardson L; Jarvius M; Nygren P; Fryknäs M; Höglund M; Larsson R
    Blood Cancer J; 2015 Apr; 5(4):e307. PubMed ID: 25885427
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Expression and clinical significance of tyrosine phosphatase SHP-2 in colon cancer.
    Cai P; Guo W; Yuan H; Li Q; Wang W; Sun Y; Li X; Gu Y
    Biomed Pharmacother; 2014 Apr; 68(3):285-90. PubMed ID: 24439672
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. SB1518, a novel macrocyclic pyrimidine-based JAK2 inhibitor for the treatment of myeloid and lymphoid malignancies.
    Hart S; Goh KC; Novotny-Diermayr V; Hu CY; Hentze H; Tan YC; Madan B; Amalini C; Loh YK; Ong LC; William AD; Lee A; Poulsen A; Jayaraman R; Ong KH; Ethirajulu K; Dymock BW; Wood JW
    Leukemia; 2011 Nov; 25(11):1751-9. PubMed ID: 21691275
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. MTGR1 is required for tumorigenesis in the murine aom/DSS colitis-associated carcinoma model.
    Barrett CW; Fingleton B; Williams A; Ning W; Fischer MA; Washington MK; Chaturvedi R; Wilson KT; Hiebert SW; Williams CS
    Cancer Res; 2011 Feb; 71(4):1302-12. PubMed ID: 21303973
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.